The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Semaglutide Market Research Report 2025
Synopsis
Oral Semaglutide is the first oral glucagon-like peptide 1 receptor agonist product for the treatment of type 2 diabetes mellitus.As a class, GLP-1 receptor agonists are widely used and recommended for the treatment of type 2 diabetes mellitus.
The global Oral Semaglutide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Semaglutide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Semaglutide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Semaglutide include Novo Nordisk, Reddy's Laboratories, Eli Lilly and Company, Shandong Shengdi Pharmaceutical Co., Ltd., Huadong Medicine, Shanghai Benemae Pharmaceutical and Aurisco, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Semaglutide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Semaglutide.
Report Scope
The Oral Semaglutide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Semaglutide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Semaglutide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Reddy's Laboratories
Eli Lilly and Company
Shandong Shengdi Pharmaceutical Co., Ltd.
Huadong Medicine
Shanghai Benemae Pharmaceutical
Aurisco
Segment by Type
Purity Above 98%
Purity Below 98%
Segment by Application
Hospitals
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Semaglutide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Semaglutide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Oral Semaglutide is the first oral glucagon-like peptide 1 receptor agonist product for the treatment of type 2 diabetes mellitus.As a class, GLP-1 receptor agonists are widely used and recommended for the treatment of type 2 diabetes mellitus.
The global Oral Semaglutide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Semaglutide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Semaglutide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Semaglutide include Novo Nordisk, Reddy's Laboratories, Eli Lilly and Company, Shandong Shengdi Pharmaceutical Co., Ltd., Huadong Medicine, Shanghai Benemae Pharmaceutical and Aurisco, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Semaglutide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Semaglutide.
Report Scope
The Oral Semaglutide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Semaglutide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Semaglutide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Reddy's Laboratories
Eli Lilly and Company
Shandong Shengdi Pharmaceutical Co., Ltd.
Huadong Medicine
Shanghai Benemae Pharmaceutical
Aurisco
Segment by Type
Purity Above 98%
Purity Below 98%
Segment by Application
Hospitals
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Semaglutide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Semaglutide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Semaglutide Market Overview
1.1 Product Overview and Scope of Oral Semaglutide
1.2 Oral Semaglutide Segment by Type
1.2.1 Global Oral Semaglutide Market Value Comparison by Type (2024-2030)
1.2.2 Purity Above 98%
1.2.3 Purity Below 98%
1.3 Oral Semaglutide Segment by Application
1.3.1 Global Oral Semaglutide Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Global Oral Semaglutide Market Size Estimates and Forecasts
1.4.1 Global Oral Semaglutide Revenue 2019-2030
1.4.2 Global Oral Semaglutide Sales 2019-2030
1.4.3 Global Oral Semaglutide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Semaglutide Market Competition by Manufacturers
2.1 Global Oral Semaglutide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Semaglutide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Semaglutide Average Price by Manufacturers (2019-2024)
2.4 Global Oral Semaglutide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Semaglutide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Semaglutide, Product Type & Application
2.7 Oral Semaglutide Market Competitive Situation and Trends
2.7.1 Oral Semaglutide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Semaglutide Players Market Share by Revenue
2.7.3 Global Oral Semaglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Semaglutide Retrospective Market Scenario by Region
3.1 Global Oral Semaglutide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Semaglutide Global Oral Semaglutide Sales by Region: 2019-2030
3.2.1 Global Oral Semaglutide Sales by Region: 2019-2024
3.2.2 Global Oral Semaglutide Sales by Region: 2025-2030
3.3 Global Oral Semaglutide Global Oral Semaglutide Revenue by Region: 2019-2030
3.3.1 Global Oral Semaglutide Revenue by Region: 2019-2024
3.3.2 Global Oral Semaglutide Revenue by Region: 2025-2030
3.4 North America Oral Semaglutide Market Facts & Figures by Country
3.4.1 North America Oral Semaglutide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Semaglutide Sales by Country (2019-2030)
3.4.3 North America Oral Semaglutide Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Semaglutide Market Facts & Figures by Country
3.5.1 Europe Oral Semaglutide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Semaglutide Sales by Country (2019-2030)
3.5.3 Europe Oral Semaglutide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Semaglutide Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Semaglutide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Semaglutide Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Semaglutide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Semaglutide Market Facts & Figures by Country
3.7.1 Latin America Oral Semaglutide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Semaglutide Sales by Country (2019-2030)
3.7.3 Latin America Oral Semaglutide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Semaglutide Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Semaglutide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Semaglutide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Semaglutide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Semaglutide Sales by Type (2019-2030)
4.1.1 Global Oral Semaglutide Sales by Type (2019-2024)
4.1.2 Global Oral Semaglutide Sales by Type (2025-2030)
4.1.3 Global Oral Semaglutide Sales Market Share by Type (2019-2030)
4.2 Global Oral Semaglutide Revenue by Type (2019-2030)
4.2.1 Global Oral Semaglutide Revenue by Type (2019-2024)
4.2.2 Global Oral Semaglutide Revenue by Type (2025-2030)
4.2.3 Global Oral Semaglutide Revenue Market Share by Type (2019-2030)
4.3 Global Oral Semaglutide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Semaglutide Sales by Application (2019-2030)
5.1.1 Global Oral Semaglutide Sales by Application (2019-2024)
5.1.2 Global Oral Semaglutide Sales by Application (2025-2030)
5.1.3 Global Oral Semaglutide Sales Market Share by Application (2019-2030)
5.2 Global Oral Semaglutide Revenue by Application (2019-2030)
5.2.1 Global Oral Semaglutide Revenue by Application (2019-2024)
5.2.2 Global Oral Semaglutide Revenue by Application (2025-2030)
5.2.3 Global Oral Semaglutide Revenue Market Share by Application (2019-2030)
5.3 Global Oral Semaglutide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Oral Semaglutide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Oral Semaglutide Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Reddy's Laboratories
6.2.1 Reddy's Laboratories Corporation Information
6.2.2 Reddy's Laboratories Description and Business Overview
6.2.3 Reddy's Laboratories Oral Semaglutide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Reddy's Laboratories Oral Semaglutide Product Portfolio
6.2.5 Reddy's Laboratories Recent Developments/Updates
6.3 Eli Lilly and Company
6.3.1 Eli Lilly and Company Corporation Information
6.3.2 Eli Lilly and Company Description and Business Overview
6.3.3 Eli Lilly and Company Oral Semaglutide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly and Company Oral Semaglutide Product Portfolio
6.3.5 Eli Lilly and Company Recent Developments/Updates
6.4 Shandong Shengdi Pharmaceutical Co., Ltd.
6.4.1 Shandong Shengdi Pharmaceutical Co., Ltd. Corporation Information
6.4.2 Shandong Shengdi Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Shandong Shengdi Pharmaceutical Co., Ltd. Oral Semaglutide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shandong Shengdi Pharmaceutical Co., Ltd. Oral Semaglutide Product Portfolio
6.4.5 Shandong Shengdi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Huadong Medicine
6.5.1 Huadong Medicine Corporation Information
6.5.2 Huadong Medicine Description and Business Overview
6.5.3 Huadong Medicine Oral Semaglutide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Huadong Medicine Oral Semaglutide Product Portfolio
6.5.5 Huadong Medicine Recent Developments/Updates
6.6 Shanghai Benemae Pharmaceutical
6.6.1 Shanghai Benemae Pharmaceutical Corporation Information
6.6.2 Shanghai Benemae Pharmaceutical Description and Business Overview
6.6.3 Shanghai Benemae Pharmaceutical Oral Semaglutide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanghai Benemae Pharmaceutical Oral Semaglutide Product Portfolio
6.6.5 Shanghai Benemae Pharmaceutical Recent Developments/Updates
6.7 Aurisco
6.6.1 Aurisco Corporation Information
6.6.2 Aurisco Description and Business Overview
6.6.3 Aurisco Oral Semaglutide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurisco Oral Semaglutide Product Portfolio
6.7.5 Aurisco Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Semaglutide Industry Chain Analysis
7.2 Oral Semaglutide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Semaglutide Production Mode & Process
7.4 Oral Semaglutide Sales and Marketing
7.4.1 Oral Semaglutide Sales Channels
7.4.2 Oral Semaglutide Distributors
7.5 Oral Semaglutide Customers
8 Oral Semaglutide Market Dynamics
8.1 Oral Semaglutide Industry Trends
8.2 Oral Semaglutide Market Drivers
8.3 Oral Semaglutide Market Challenges
8.4 Oral Semaglutide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
